NEW JERSEY — Attorney General Matthew J. Platkin expressed gratitude following a Supreme Court decision that ensures continued nationwide access to mifepristone for abortion care and miscarriage management. The ruling, delivered today, June 13, 2024, unanimously found that the case against the FDA’s approval of the drug lacked standing as the challengers were not directly harmed by the FDA’s actions.
Attorney General Platkin warned of ongoing threats to reproductive health care, citing personal testimonies he heard during a recent visit to Texas about the severe health risks faced due to persistent attacks on such care. He reaffirmed his commitment, alongside Governor Phil Murphy, to safeguarding reproductive rights in New Jersey, vowing to prevent similar adversities from affecting the state.
